Biotech

All Articles

A more detailed consider Strong Biotech's Brutal 15

.In this full week's incident of "The Best Line," our team are actually diving right into Brutal Bio...

Lilly deals with stage 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration commemorating the commendation of Alzheim...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings as wel...

Lykos will certainly talk to FDA to reconsider its selection complying with denial of MDMA therapy for post-traumatic stress disorder

.Following an unsatisfactory revealing for Lykos Rehabs' MDMA prospect for trauma at a latest FDA ad...

AN 2 one-halfs roll call, ceases period 3 test after information let down

.AN2 Rehabs is actually rethinking its organization in feedback to poor midphase data, pledging to g...

Merck spends $700M for bispecific, snooping autoimmune position and chance to test Amgen in cancer cells

.Merck &amp Co. is actually paying $700 million in advance to test Amgen in a blood stream cancer ma...

Gilead spends J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver illness drug seladelpar, the firm h...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can find the business putting together tents at basecamp respon...

Entero giving up staff, moving out of workplace as well as stopping briefly R&ampD

.Bed mattress Liquidators has switched Entero Therapies white colored as a piece. The creditor order...

Exelixis loses ADC after choosing it is actually no suit for Tivdak

.Exelixis is quiting on its own tissue element (TF)- targeting antibody-drug conjugate after ending ...